Portland, OR -- (SBWIRE) -- 06/12/2018 -- The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines repair, replace, and regenerate tissues and organs affected due to injury, disease, or natural ageing process. These medicines help restore the functionality of cells & tissues and are applicable in numerous degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications. Researchers focus on developing technologies based on biologics, genes, somatic as well as stem cells. Stem cells are capable of proliferation and differentiation and hence, are critical in this field.
For More Info, Get Sample : https://www.researchbeam.com/regenerative-medicines-market/request-sample
The major factors that boost the market growth include technological advancements in tissue and organ regeneration, increase in prevalence of chronic diseases and trauma emergencies, prominent potential of nanotechnology, and emergence of stem cell technology. In addition, rise in degenerative diseases and shortage of organs for transplantation are expected to fuel the growth of the market. Moreover, utilization of nanomaterials in wound care, drug delivery, and immunomodulation has opened numerous growth avenues for the regenerative medicines market. However, stringent regulatory barriers and high cost of the treatment are likely to hinder the market growth.
The global regenerative medicine market is segmented based on product type, material, application, and geography. Based on product type, the market is classified into cell therapy, gene therapy, tissue engineering, and small molecule & biologic. Depending on material, it is categorized into synthetic material, biologically derived material, genetically engineered material, and pharmaceutical. Synthetic material is further divided into biodegradable synthetic polymer, scaffold, artificial vascular graft material, and hydrogel material. Biologically derived material is further bifurcated into collagen and xenogenic material. Genetically engineered material is further segmented into deoxyribonucleic acid, transfection vector, genetically manipulated cell, three-dimensional polymer technology, transgenic, fibroblast, neural stem cell, and gene-activated matrices. Pharmaceutical is further divided into small molecule and biologic. By application, it is categorized into cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. Geographically, it is analyzed across four regions, i.e., North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
- This report offers a detailed quantitative analysis of the market trends from 2016 to 2023 to identify the prevailing opportunities.
- The market estimations provided in this report are based on a comprehensive analysis of the key developments in the industry.
- An in-depth analysis based on geography facilitates the study of the regional market to assist in strategic business planning.
- The development strategies adopted by the key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
Enquire About Report : https://www.researchbeam.com/regenerative-medicines-market/enquire-about-report
By Product Type
- Cell Therapy
- Gene Therapy
- Tissue Engineering
- Small Molecule & Biologic
By Material
- Synthetic Material
- Biodegradable Synthetic Polymer
- Scaffold
- Artificial Vascular Graft Material
- Hydrogel Material
- Biologically Derived Material
- Collagen
- Xenogeneic Material
- Genetically Engineered Material
- Deoxyribonucleic Acid Transfection Vectors
- Genetically Manipulated Cell
- Three-Dimensional Polymer Technology
- Transgenic
- Fibroblast
- Neural Stem Cell
- Gene-Activated Matrices
- Pharmaceuticals
- Small Molecule
- Biologic
By Application
- Cardiovascular
- Oncology
- Dermatology
- Musculoskeletal
- Wound Healing
- Ophthalmology
- Neurology
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Netherlands
- Sweden
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- Singapore
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
Also Request For Discount : https://www.researchbeam.com/regenerative-medicines-market/purchase-enquiry
KEY PLAYERS PROFILED
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Medtronic Plc.
- Athersys, Inc.
- U.S. Stem Cell, Inc. (Bioheart, Inc.)
- Organogenesis, Inc. (Advanced Biohealing)
- Integra Lifesciences Holdings Corporation
- Acelity Holdings, Inc.
- Isto Biologics (Isto Biologics Medical Systems, Inc.)
- CryoLife, Inc.
The other players of the Regenerative Medicine market include (companies not profiled in the report):
- Shimadzu Recursion Pharmaceuticals, Inc.
- Baxter International, Inc.
- DePuy Synthes
- Siemens Healthineers
- General Electric (GE) Company
- Koninklijke Philips N.V.
- Cloudmedx, Inc.
- Bay Labs, Inc.
Table Of Content
- CHAPTER 1: INTRODUCTION
- CHAPTER 2: EXECUTIVE SUMMARY
- CHAPTER 3: MARKET OVERVIEW
- CHAPTER 4: REGENERATIVE MEDICINE MARKET, BY PRODUCT TYPE
- CHAPTER 5: REGENERATIVE MEDICINE MARKET, BY MATERIAL
- CHAPTER 6: REGENERATIVE MEDICINE MARKET, BY APPLICATION
- CHAPTER 7: REGENERATIVE MEDICINE MARKET, BY REGION
- CHAPTER 8: COMPANY PROFILES
About Research Beam
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.
Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com